The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-α) gene and ex vivo lipopolysaccharide-induced TNF-α expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus

European Cytokine Network

Volumn 15, Issue 4, 2004, Pages 364-370

  Pérez, Claudio ^a   González, Fermín E ^a,b   Pavez, Violeta ^c   Araya, Aida V ^b   Aguirre, Adam ^a   Cruzat, Andrea ^a   Contreras Levicoy, Juan ^a   Dotte, Andrés ^a   Aravena, Octavio ^a   Salazar, Lorena ^a   Catalán, Diego ^a   Cuenca, Jimena ^a   Ferreira, Arturo ^a   Schiattino, Irene ^a   Aguillón, Juan C ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Cytokine; Diabetes; Periodontitis; Polymorphism; Promoter; TNF gene promoter; Tumor necrosis factor; Type 1 diabetes mellitus

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTITIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; PERIODONTITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 19944433491     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Haber J, Wattles J, Crowley R, Mandell R, Joshipura K, Kent R. Assessment of diabetes as a risk factor for periodontitis. J Dent Res 1991; 70: 414; special issue IADR abstracts.
2. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994; 65: 260.
3. Research Science and Therapy Committee of the American Academy of Periodontology. Diabetes and periodontal diseases. J Periodontol 1999; 70: 935.
4. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996; 1: 821.
5. Hassel TM, Harris EL. Genetic influences in caries and periodontal diseases. Crit Rev Oral Biol Med 1995; 6: 319.
6. Hart TC, Kornman KS. 1997. Genetic factors in the pathogenesis of periodontitis. Periodontol 2000; 14: 202.
7. Wilson AG, Di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992; 1: 353.
8. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195.
9. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 1999; 66: 562.
10. Mc Guire W, Hill ASW, Allsop CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508.
11. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun 2000; 1: 351.
12. Rood MJ, Van Krugten MV, Zanelli E, et al. TNF -308 and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129.
13. Rudwaleit M, Siegert S, Yin Z, et al. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001; 60: 36.
14. Cuenca J, Cuchacovich M, Perez C, et al. The -308 polymorphism in the tumor necrosis factor gene promoter region and ex - vivo lipopolysaccharide- induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology 2003; 42: 308.
15. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24: 72.
16. Shapira L, Stabholz A, Rieckmann P, Kruse N. Genetic polymorphism of the tumor necrosis factor (TNF)-alpha promoter region in families with localized early-onset periodontitis. J Periodont Res 2001; 36: 183.
17. Craandijk J, Van Krugten MV, Verweij CL, Van der Velden U, Loos BG. Tumor necrosis factor-alpha gene polymorphisms in relation to periodontitis. J Clin Periodontol 2002; 29: 28.
18. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4: 1.
19. American Diabetes Association Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Committee Report. Diabetes Care 1997; 20: 1183.
20. Araya AV, Pavez V, Perez C, et al. Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis. Eur Cytokine Netw 2003; 14: 128.
21. Aguillón JC, Escobar A, Ferreira V, et al. Daily production of human tumor necrosis factor in lipopolysaccharide (LPS)-stimulated ex vivo blood culture assays. Eur Cytokine Netw 2001; 12: 105.
22. StataCorp. STATA Statistical Software: Release 5.0. College Station. U.S.A: TX: Stata Corporation, 1997.
23. Cairo F, Rotundo H, Frazzingaro G, Muzzi L, Pini Prato GP. Diabetes mellitus as a risk factor for periodontitis. Stomatology 2001; 50: 321.
24. Todd JA. Genetic control of autoimmunity in IDDM. Immunol Today 1990; 11: 122.
25. Dawkins RL, Martin E, Saueracker G, Kay PH, Leaver A, Christiansen FT. Supratypes and ancestral haplotypes in IDDM; potential importance of central non-HLA MHC genes. J Autoimmun 1990; 3: 63.
26. Christiansen FT, Saueracker G, Leaver A, Tokunaga K, Cameron PU, Dawkins RL. Characterization of MHC ancestral haplotypes associated with insulin-dependent diabetes mellitus: evidence for involvement of non-HLA genes. J Immunogenet 1990; 17: 379.
27. Cox A, Gonzalez AM, Wilson AG, et al. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 1994; 37: 500.
28. Michalowicz BS. Genetic and heritable risk factor in periodontal disease. J Periodontol 1994; 65: 479.
29. Ohyama H, Takashiba S, Oyaizu K. HLA class II genotypes associated with early onset periodontitis: DQB1 molecule primarily confers susceptibility to the disease. J Periodontol 1996; 67: 888.
30. Firatli E, Kantarci A, Cebeci I, et al. Association between HLA antigens and early onset periodontitis. J Clin Periodontol 1996; 23: 563.
31. Grossi SG. Treatment of periodontal disease and control of diabetes: an assessment of evidence and need for future research. Rev Ann Periodontol 2001; 6: 138.
32. Lacopino AM. Periodontitis and diabetes interrelationships; role of inflammation. Ann Periodontol 2001; 6: 125.
33. Kornman KS, Di Giovine FS. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Periodontol 2000 1998; 3: 327.
34. Galbraith GMP, Hendley TM, Sanders JJ, Palesch Y, Pandey JP. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol 1999; 26: 705.
35. Lang NP, Tonetti MS, SuterJ, Sorrell J, Duff GW, Kornman KS. Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J Periodont Res 2000; 35: 102.
36. Pociot F, Wilson AG, Nerup J, Duff GW. No independent association between a tumor necrosis factor-alpha promoter region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 3050.
37. Endo M, Tai H, Tabeta K, Kobayashi T, Yamazaki K, Yoshie H. Analysis of single nucleotide polymorphisms in the 5′-flanking region of tumor necrosis factor-alpha gene in Japanese patients with early-onset periodontitis. Periodontology 2001; 72: 1554.
38. Folwaczny M, Glas J, Torok HP, Mende M, Folwaczny C. Lack of association between the TNF alpha G -308 A promoter polymorphism and periodontal disease. J Clin Periodontol 2004; 31: 449.
39. Fassmann A, Holla LI, Buckova D, Vasku A, Znojil V, Vanek J. Polymorphisms in the +252(A/G) lymphotoxin-alpha and the -308(A/G) tumor necrosis factor-alpha genes and susceptibility to chronic periodontitis in a Czech population. J Periodontal Res 2003; 38: 394.
40. Galbraith G, Britt Sted R, Sanders JJ, Pandey JP. Tumor necrosis factor-alpha production by oral leukocytes: Influence of tumor necrosis factor genotype. J Periodontol 1998; 69: 428.
41. Lin L, Pan YP, Yin LY. Study on the correlation of cytokine gene polymorphism with chronic periodontitis. Shanghai Kou Qiang Yi Xue 2003; 12: 456.
42. Cuenca J, Pérez C, Aguirre A, Schiattino I, Aguillón JC. Genetic polymorphism at position -308 in the promoter region of the tumor necrosis factor (TNF): Implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population. Biol Res 2001; 34: 237.
43. Bouma G, Crusius JB, Oudkerk Pool M, et al. Secretion of tumour necrosis factor and lymphotoxin in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996; 43: 456.
44. Kroeger K, Carville KS, Abraham L. The -308 tumor necrosis factor- promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391.
45. Louis E, Franchimont D, Piron A, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF- production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401.
46. Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359.
47. Bayley JP, de Rooij H, Van der Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF promoter. Cytokine 2001; 14: 316.
48. 2 shows stable inter-individual differences. Scand J Immunol 1988; 27: 705.
49. Fokkema SJ, Loos BG, Slegte C, Van der Velden U. A type-2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients. Clin Exp Immunol 2002; 127: 374.
50. Salvi GE, Yalda B, Collins JG, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997; 68: 127.
51. Yalda B, Offenbacher S, Collins JG. 1994. Diabetes as a modifier of periodontal disease expression. Periodontol 2000; 6: 37.
52. Kaijzel EL, Bayley JP, Van Krugten MV, et al. Allele-specific quantification of tumor necrosis factor (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immunity 2001; 2: 135.
53. Yavuzyilmaz E, Yamalik N, Bulut S, Ozen S, Ersoy F, Saatci U. The gingival crevicular fluid interleukin-1 beta and tumour necrosis factor-alpha levels in patients with rapidly progressive periodontitis. Aust Dent J 1995; 40: 46.
54. Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 2000; 248: 67.